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Background: Risk factors associated with Clostridium difﬁcile infection (CDI) in general surgical patients
are poorly characterised. This study aimed to characterise the incidence and associations of C. difﬁcile
positivity (CDP) in general surgical inpatients to aid in the design of future policies regarding focused
screening and risk-stratiﬁcation mechanisms in this patient subpopulation.
Materials and methods: Discharge, laboratory and coding data from all general surgery inpatients
admitted to a large tertiary referral general surgical unit, between March 2005 and May 2007, were
examined.
Results: 21,371 patient records were interrogated. 101 (0.47%) CDP cases were identiﬁed from laboratory
records and compared with non-CDP controls for age, gender, length of stay (LOS), admission to intensive
care unit or high dependency unit (ICU/HDU), co-morbidities and surgical procedures. Univariate anal-
ysis identiﬁed a range of risk factors associated with positivity.
Multivariate analysis identiﬁed malignancy, gastrointestinal disease, anaemia, respiratory disease,
circulatory disease, diabetes mellitus, those undergoing gastrointestinal surgery and increasing age to be
independently associated with CDP status.
Conclusions: This study identiﬁes incidence and risk factor associations of those who tested CDP in a large
contemporary general surgery inpatient population. Focused screening programmes based on high-risk
populations may provide information on further risk factors and allow risk-stratiﬁcation.
Further healthcare worker education regarding risk factors may reduce the clinical impact of CDI by
encouraging increased vigilance and therefore earlier detection.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Recent studies show that whilst the incidence and severity of
methicillin-resistant Staphylococcus aureus infection is decreasing,
the incidence of Clostridium difﬁcile infection (CDI) is continuing to
escalate1,2 with increasing resistance to medical therapy.3
CDI can causea spectrumofdisease fromasymptomatic colonisation
toenteric illnesses including fulminantpseudomembranouscolitis.4The
consequences of CDI can be important to both the individual and
healthcare institution, includingan increasedriskofmortality (upto25%epartment of Microbiology,
þ44 07754367465.
.A. Rodrigues), apgibb@gmail.
ciates Ltd. Published by Elsevier Ltin elderly patients),2 higher risk of additional infections, longer length of
stay (LOS) and ward closures in order to control outbreaks.5,6 CDI
increases the cost of managing a patient by 54%,7,8 with estimates sug-
gesting CDI costs an average-sized district general hospital £400,000
with more than 2000 lost bed days annually.9
Despite a myriad of infection control measures, such as hand
hygiene, environmental cleaning and prudent antibiotic steward-
ship, introduced throughout the UK to tackle the growing CDI
problem, the increasing incidence of CDI10 suggests that these
measures are only partially effective. Whilst general measures such
as effective infection control programmes have been shown to
reduce infection trends,11 such measures may be more successful if
they are targeted towards high-risk inpatient populations,
providing a more focused approach to primary prevention.
In addition, screening patients for C. difﬁcile status may also
provide an alternative approach. Prompt identiﬁcation of CDI cand. All rights reserved.
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treatment11 and rapid isolation of infected patients can reduce
environmental contamination, helping control the transmission of
C. difﬁcile.12 Furthermore, as asymptomatic carriers of C. difﬁcile are
a potential source for transmission,4,13 identifying and treating
these patients may help reduce the spread of CDI, although results
from such studies are conﬂicting.14e16 However, as faecal carriage of
C. difﬁcile does not correlate with CDI,13 screening all patients could
lead to over-excessive or unnecessary treatment and paradoxically
increase the patients’ risks of developing CDI.17 Therefore any
screening programme should be targeted to patients with the
highest risk of developing CDI and more work on the effectiveness
of this modality as an intervention to reduce CDI incidence is
required.
Whilst much work has concentrated on risk factor associations
in medical patients,17 there are few studies speciﬁcally examining
rates of infection within the general surgical inpatient populations.
CDI rates of 4.2% in colorectal patients and 5% of liver transplant
recipients have been reported,18,19 but recent epidemiology of CDI
may be changing in view of outbreaks caused by hyper-virulent
strains of C. difﬁcile, with up to 53% mortality and a 23% rate of
colectomy.20 As such, there is a need for accurate contemporary
data on the incidence of CDI and a means to potentially identify
those patient populations at increased risk. This provides a method
to risk stratify those patients for increased surveillance.
Here we examine a large general surgical inpatient population,
in order to quantify both the impact of infection on outcome and
the factors associated with infection within this speciﬁc inpatient
population.
2. Methods
Discharge summaries relating to all hospitalised general surgery
inpatients at the Royal Inﬁrmary of Edinburgh (RIE), UK, results of
all C. difﬁcile cytotoxin assays from the RIE Microbiology Database
and complete data from the Discharge Coding Database at the RIE,
betweenMarch 2005 andMay 2007, was examined retrospectively.
Patient demographics included date of birth, gender, dates of
admission and discharge, mortality, ICU/HDU admission, patient
co-morbidities (ICD-10 codes), and surgical procedures performed
(OPSC4 codes). C. difﬁcile positive (CDP) status was ascertained
from positive stool samples recorded by the microbiology database
which recorded those samples that had been taken by clinical staff
when clinically indicated. Stool samples were either tested on the
day of collection for the presence of C. difﬁcile toxin A or B (C. difﬁcile
TOX A/B II, TECHLAB, USA), or if delayed, were stored at 4

C and
tested within 24 h. Positive assay for C. difﬁcile toxin A and/or toxin
B in those who had clinically-indicated testing deﬁned CDP status.
Only the ﬁrst CDP episode during the study period for each case
was recorded as a positive result, subsequent episodes were
excluded from the analysis (n ¼ 17).
21,270 general surgical inpatient admissions who were
admitted during the study period andwho did not prove CDP status
positive during their admission were used as a comparison pop-
ulation. Only the ﬁrst admissions during the study period for
patients in the comparison populationwere used, 2097 subsequent
inpatient episodes within the study periodwere therefore excluded
from analysis.
19/103 (18.4%) of the CDP cases had missing data from the
discharge coding database. Medical case notes for these 19 cases
were therefore sought from medical records, with data subse-
quently obtained for 17. 8327/29,597 (28.1%) of the control pop-
ulation had missing data ﬁelds from the discharge coding database
and were excluded from analysis. General surgical patients
admitted to the general surgical department but who did not stayin the general surgery wards, or those who stayed in general
surgical wards but were not general surgical inpatients were also
excluded from the data analysis.
2.1. Statistical analysis
ShapiroeWilks tests were performed to assess the normality of
the data. To examine demographical differences in CDP status, two-
sample t-tests have been used for continuous data, with chi-square
tests or Fishers exact tests as appropriate used for categorical data.
LOS, and time between admission, CDP status and discharge, data
follows a non-normal distribution and in these cases a Man-
neWhitney U test has been used. As a number of factors were found
to be related to CDP status, a multivariable logistic regression was
performed on those felt to bemost clinically relevant [age, diabetes,
respiratory disease, anaemia, circulatory disease, malignancy,
gastrointestinal disease, renal failure and gastrointestinal surgery].
Permissions for this study were sought from the University of
Edinburgh prior to the study.
3. Results
3.1. Patient population
31,814 surgical admissions involving 29,700 general surgical
patients were analysed. 101 cases were identiﬁed as CDP and
compared with 21,270 non-CDP patients. 2 CDP cases (1.98%) and
8327 non-CDP patients (28.1%) were excluded due to missing data.
The incidence of patients with a CDP status was 4.73 per 1000
admissions.
3.2. Demographics
CDP patients were signiﬁcantly older than non-CDP patients
[mean (SD) 65.3 (17.6) vs. 51.1 (20.1), p < 0.001]. Age was inde-
pendently associated with a positive result for C. difﬁcile (OR¼ 1.02,
95% CI (1.01, 1.04)], p < 0.001; where the odds ratio gives the cor-
responding increase in odds for an increase in age of a single year).
Gender was not associated with CDP status. Within the CDP pop-
ulation 52 (51.5%) CDP cases were male, whilst in the control group
9793 (46.0%) were male (p ¼ 0.274).
3.3. Co-morbidities
Patient variables, including co-existing pathology and surgical
interventions, were examined for an association with CDP status.
Univariate analysis identiﬁed a number of co-pathologies which
were signiﬁcantly associated with CDP status (Table 1.).
Multivariate analysis was therefore subsequently performed on
the eight univariate analysis variables felt to be most clinically
relevant. This demonstrated that the following factors were inde-
pendently associated with positive C. difﬁcile status: Age
(p < 0.001), gastrointestinal disease (p < 0.001), malignancy
(p < 0.001), respiratory disease (p < 0.001), circulatory disease
(p < 0.001), diabetes mellitus (p < 0.05), anaemia (p < 0.05) and
gastrointestinal surgery (p < 0.05) (c-index ¼ 0.788) (Table 2).
3.4. Outcomes
Themedian LOS for CDP cases was signiﬁcantly longer than non-
CDP controls (16 days [interquartile range (IQR) 8e33] versus 2
days [IQR 1e5], p < 0.001). For cases, the median number of days
from admission to the surgery wards until CDP status and from CDP
status until discharge were both signiﬁcantly longer than the total
Table 1
Univariate analysis of characteristics of C. difﬁcile positive general surgery inpatients and non-infected controls.
Characteristic Clostridium difﬁcile
positive patients
[N ¼ 101] (%)
Non-infected controls
[N ¼ 21,270] (%)
Chi-squared value P-value Odds ratio (95% CI)
co-existing infection 28 (27.7) 1336 (6.3) 77.3 <0.001 5.72 (3.69e8.88)
Diabetes mellitus 9 (8.9) 560 (2.6) 15.3 <0.001 3.62 (1.82e7.21)
Circulatory disease 29 (28.7) 2039 (9.6) 42.1 <0.001 3.80 (2.46e5.86)
Malignancy 26 (25.7) 2007 (9.4) 31.1 <0.001 3.33 (2.12e5.21)
GI tract 24 (23.8) 1363 (6.4) 49.1 <0.001 4.55 (2.87e7.22)
GI disease 81 (80.2) 12075 (56.8) 22.5 <0.001 3.08 (1.89e5.03)
Liver disease 13 (12.9) 923 (4.3) 17.5 <0.001 3.26 (1.81e5.85)
Disease of the gall bladder,
biliary tract or pancreas
40 (39.6) 5678 (26.7) 8.5 0.003 1.80 (1.21e2.69)
Peptic ulcer 8 (7.9) 478 (2.2) 14.6 <0.001 3.74 (1.81e7.75)
GI haemorrhage 9 (8.9) 200 (0.9) 65.9 <0.001 10.31 (5.13e20.72)
Respiratory disease 19 (18.8) 978 (4.6) 45.7 <0.001 4.81 (2.91e7.95)
Renal failure 8 (7.9) 521 (2.5) 12.5 <0.001 3.43 (1.66e7.09)
Obesity 4 (4.0) 163 (0.8) a 0.008 5.34 (1.94e14.7)
Complications of surgical
& medical care
20 (19.8) 1061 (5.0) 45.9 <0.001 4.70 (2.87e7.70)
Disorders of CNS 6 (5.9) 229 (1.1) 21.9 <0.001 5.80 (2.52e13.38)
Anaemia 8 (7.9) 377 (1.8) 21.5 <0.001 4.77 (2.30e9.89)
Upper GI endoscopy 7 (6.9) 962 (4.5) 1.4 0.240 1.57 (0.73e3.40)
Surgery 62 (61.4) 14528 (68.3) 2.2 0.138 0.74 (0.49e1.10)
GI surgery 45 (44.6) 6608 (31.1) 8.6 0.003 1.78 (1.20e2.64)
Upper GI surgery 14 (13.9) 1722 (8.1) 4.6 0.033 1.84 (1.04e3.24)
Liver, pancreas & Gall bladder surgery 27 (26.7) 4138 (19.5) 3.5 0.061 1.51 (0.97e2.35)
Pancreas surgery 6 (6.0) 27 (0.1) 180.1 <0.001 49.7 (20.1e123.1)
Endoscopic retrograde procedure 5 (5.0) 265 (1.2) 11.1 <0.001 4.13 (1.67e10.23)
Lower GI surgery 7 (6.9) 1004 (4.7) 1.0 0.314 1.50 (0.70e3.25)
Male gender 52 (51.5) 9793 (46.0) 1.2 0.274 1.24 (0.84e1.84)
ICU/HDU admission 47 (46.5) 3100 (14.6) 81.8 <0.001 5.10 (3.44e7.56)
Death 5 (5.0) 113 (0.5) 35.8 <0.001 9.75 (3.89e24.4)
CI ¼ conﬁdence interval, GI ¼ gastrointestinal, CNS ¼ central nervous system, ICU ¼ intensive care unit, HDU ¼ high dependency unit.
a Fishers’ exact test used when a cell value <5 in the two-by-two table.
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4e30], p < 0.001, respectively).
Admission to ICU/HDU was signiﬁcantly associated with CDP
status; 47 (46.5%) cases were admitted to ICU/HDU during their
hospitalisation compared with 3100 (14.6%) controls (p < 0.001).
Mortality during the hospitalised periodwas signiﬁcantly increased
by 10-fold in CDP patients compared to controls (5.0% versus 0.53%,
p < 0.001)
4. Discussion
This study provides contemporary data on the incidence and
variables associated with C. difﬁcile positivity in symptomatic
general surgical inpatient populations. The incidence of C. difﬁcile
positivity reported here is reﬂective of the non-outbreak environ-
ment and is in keeping with previous studies.21 It is considerably
lower than that reported in previous reports in patients withinTable 2
Multivariate analysis of characteristics of C. difﬁcile positive general surgery inpatients a
Characteristic Clostridium difﬁcile positive
patients [N ¼ 101] (%)
Non-infected
controls [N ¼ 21,27
Diabetes mellitus 9 (8.9) 560 (2.6)
Circulatory disease 29 (28.7) 2039 (9.6)
Malignancy 26 (25.7) 2007 (9.4)
GI disease 81 (80.2) 12075 (56.8)
Respiratory disease 19 (18.8) 978 (4.6)
Anaemia 8 (7.9) 377 (1.8)
GI surgery 45 (44.6) 6608 (31.1)
Age N/A N/A
CI ¼ conﬁdence interval, GI ¼ gastrointestinal.medical specialties (0.47% versus 6.8e12.7%).22,23 Whilst our anal-
ysis suggests factors associated with C. difﬁcile positivity in general
surgery inpatients are broadly similar to those identiﬁed in other
inpatient populations17,24 further work is required to directly
compare surgical and non-surgical population groups in order to
explore the variation in the reported incidence of CDP.
Increasing age has consistently been identiﬁed as a risk factor
associated with CDI.23 Decreasing immunity and gastric acid
production with age, in addition to the greater chance of exposure
to C. difﬁcile due to increasing hospital visits and nursing home
residency, could be partly responsible for this trend.23 However, the
higher mortality rates associated with CDI in older patients
emphasises the importance of prevention and early detection in
this group.2 An association between female gender and CDI has
been reported by previous studies,22,25 however evidence is con-
ﬂicting.17 This study found no signiﬁcant association between
gender and CDP status.nd non-infected controls.
0] (%)
Chi-squared value P-value Odds ratio (95% CI)
4.7 0.031 2.19 (1.08e4.44)
12.5 <0.001 2.29 (1.45e3.62)
24.4 <0.001 3.43 (2.10e5.58)
19.8 <0.001 3.31 (1.96e5.61)
14.5 <0.001 2.74 (1.63e4.60)
8.2 0.004 2.97 (1.41e6.24)
9.6 0.002 1.87 (1.26e2.78)
12.2 <0.001 1.02 (1.01e1.04)
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association with CDI.1,17 The relatively large number of antibiotics
and invasive devices used in ICU/HDU may account for its associ-
ation with CDI,1 but admission to ICU/HDU may also be a result of
CDI. As such, it is difﬁcult to statistically discriminate a cause or
effect phenomenon related to CDI and ICU/HDU admission using
our current data sources. The median length of time from admis-
sion until CDP status (6 days) and from CDP status until discharge
(11 days) was both signiﬁcantly longer than the total LOS of non-
CDP cases (2 days). This suggests increased LOS is both a risk factor
for C. difﬁcile positivity and also a consequence of it.
Surgical management of severe CDI has a poor prognosis, with
mortality rates ranging from 46 to 67%.26,27 Of note, within our
study, symptomatic CDP status was enough to cause a 10-fold
increase in patients risk of mortality. The mortality rate in this
study was lower than reported in some studies (5.0% versus
12.7e25%),2,22 but the strains of C. difﬁcile involved, decreased
severity of CDI and improved or early management of CDI could
account for these differences.
Of note, there are some weaknesses in the current study. In
some cases, symptomatic testing may have been inappropriate. In
addition, non-CDP cases included patients with symptoms
suggestive of CDI who tested negative for C. difﬁcile toxins or were
not tested, and general surgery patients who were never tested.
Whilst a small proportion of all inpatients are known C. difﬁcile
carriers and would be CDP if tested, these patients should be
asymptomatic by deﬁnition and therefore not proceed to testing,
therefore minimising the impact of such carriers. The size of the
non-CDP population also mitigates the inﬂuence of these con-
founding effects on data conclusions.
The two groups being studied varied in size. It is possible that
some statistical differences observed are due to this discrepancy in
group size. As such, the results should be interpreted in terms of
clinically meaningful effect sizes as well as p-values.
The study was limited to coding data only and therefore could
not address other known associations such as nursing home resi-
dency and medication use, such as antibiotics, proton pump
inhibitors, chemotherapy, or invasive device use, such as catheters
or feeding tubes, which have been previously linked with CDI.1,17,28
Wewere also unable to identify patients who developed CDP status
after discharge from the general surgical department. Errors may
have arisen from inaccurate discharge summaries or imprecise
coding. Finally, a proportion of patients were excluded due to
missing data. Records were sought for the 19 CDP cases with
missing data, with 17 of these patients subsequently included. The
large control group size, in addition to the data enrichment of the
CDP group and the high quality of baseline data was felt to partially
mitigate the effect of missing data on analysis.
The particular case mix of the hospital concerned should be
noted. RIE provides upper gastrointestinal, hepatobiliary and
transplant surgery services for Edinburgh, as well as emergency
surgery. Colorectal surgery is provided by a separate unit at an
alternative site (Western General Hospital). The absence of asso-
ciation between C. difﬁcile positivity and lower gastrointestinal
surgery, which has been previously demonstrated in other work,21
may be the result of the small sample size of these types of surgical
cases at the RIE. However, if analysis had included the tertiary
referral of advanced C. difﬁcile patients to the Western General
colorectal wards from regional hospitals, this could over represent
C. difﬁcile in the baseline surgical population.
In conclusion, this study identiﬁes risk factors associated with C.
difﬁcile positivity within a large UK general surgery population.
Through the identiﬁcation of high-risk populations, focused
surveillance and increased vigilance may allow for early detection
and isolation of affected inpatients, preventing outbreaks. However,further prospectivework assessing the beneﬁts of risk-stratiﬁcation
with regards to improved outcomes is urgently required.
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